We are live on ! Find out more
FA

Forefront Analytics Portfolio holdings

AUM $110M
1-Year Est. Return 18.54%
This Fund
S&P 500
This Quarter Est. Return
+6.65%
1 Year Est. Return
+18.54%
3 Year Est. Return
+33.55%
5 Year Est. Return
+24.76%
10 Year Est. Return
AUM
$104M
AUM Growth
+$14.3M
Cap. Flow
+$8.2M
Cap. Flow %
7.89%
Top 10 Hldgs %
76.93%
Holding
45
New
2
Increased
20
Reduced
20
Closed
2

Sector Composition

Rank Sector Weight
1 Healthcare 3.01%
2 Technology 2.51%
3 Financials 1.01%
4 Industrials 0.5%
5 Consumer Staples 0.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNH icon
26
UnitedHealth
UNH
$387B
$390K 0.38%
1,130
+396
+54% +$120K
UWM icon
27
ProShares Ultra Russell2000
UWM
$277M
$368K 0.35%
7,945
+38
+0.5% +$1.6K
EW icon
28
Edwards Lifesciences
EW
$49.4B
$349K 0.34%
4,492
+47
+1% +$3.67K
PFE icon
29
Pfizer
PFE
$143B
$320K 0.31%
12,578
-850
-6% -$21K
INCY icon
30
Incyte
INCY
$23.4B
$318K 0.31%
3,744
-1,350
-27% -$107K
HYG icon
31
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.9B
$262K 0.25%
3,229
+46
+1% +$3.71K
DHR icon
32
Danaher
DHR
$144B
$260K 0.25%
+1,313
New +$261K
TIP icon
33
iShares TIPS Bond ETF
TIP
$14.5B
$246K 0.24%
2,211
-241
-10% -$26.6K
IGF icon
34
iShares Global Infrastructure ETF
IGF
$10.9B
$239K 0.23%
3,905
REGN icon
35
Regeneron Pharmaceuticals
REGN
$70.9B
$232K 0.22%
412
-78
-16% -$44.1K
PM icon
36
Philip Morris
PM
$301B
$231K 0.22%
1,424
+11
+0.8% +$1.85K
LQD icon
37
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$35.2B
$222K 0.21%
1,991
+16
+0.8% +$1.76K
ZURA icon
38
Zura Bio
ZURA
$518M
$93.2K 0.09%
21,518
-42,467
-66% -$76.4K
ANNX icon
39
Annexon
ANNX
$950M
$82.4K 0.08%
27,027
-548
-2% -$1.36K
NKTX icon
40
Nkarta
NKTX
$186M
$81.7K 0.08%
39,452
+11,473
+41% +$23.6K
GERN icon
41
Geron
GERN
$924M
$71.6K 0.07%
52,258
+17,077
+49% +$22.7K
MREO
42
Mereo BioPharma
MREO
$49.5M
$68.4K 0.07%
33,180
+14,042
+73% +$25.9K
CTMX icon
43
CytomX Therapeutics
CTMX
$788M
$57.8K 0.06%
18,109
-9,589
-35% -$21.6K
INDA icon
44
iShares MSCI India ETF
INDA
$6.83B
-7,426
Closed -$413K
TMO icon
45
Thermo Fisher Scientific
TMO
$198B
-891
Closed -$361K

Similar funds

Forefront Analytics's Q3 2025 Portfolio in Review

As of Q3 2025, Forefront Analytics held 45 positions worth $104M, up 16% from $89.5M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Forefront Analytics deployed $8.2M of net new capital in Q3 2025, opening 2 new positions and adding to 20 existing holdings. Its largest new stake was FlexShares STOXX Global ESG Select Index Fund: 24,370 shares worth $4.81M.

By sector, the portfolio is most concentrated in Healthcare at 3% of assets, down from 3.3% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Nuveen ESG Large-Cap Value ETF, an estimated $4.18M trimmed.

  • Forefront Analytics's largest Q3 2025 buy was FlexShares STOXX Global ESG Select Index Fund: 24,370 shares worth $4.81M.
  • Forefront Analytics added most to iShares ESG Aware MSCI EAFE ETF in Q3 2025, an estimated $10.2M increase.
  • Forefront Analytics's biggest Q3 2025 reduction was Nuveen ESG Large-Cap Value ETF, cutting an estimated $4.18M.
  • Forefront Analytics fully exited iShares MSCI India ETF in Q3 2025, selling an estimated $413K.
  • Forefront Analytics's ten largest holdings make up 77% of its $104M portfolio in Q3 2025.
  • Forefront Analytics opened 2 new positions and closed 2 in Q3 2025.
  • Forefront Analytics's portfolio value rose 16% quarter-over-quarter to $104M.

Based on Forefront Analytics's 13F filing for Q3 2025, filed 21 Nov 2025.